000 01129 a2200349 4500
005 20250516120337.0
264 0 _c20130626
008 201306s 0 0 eng d
022 _a1863-2300
024 7 _a10.1007/s00281-012-0356-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBassendine, M F
245 0 0 _aLipids and HCV.
_h[electronic resource]
260 _bSeminars in immunopathology
_cJan 2013
300 _a87-100 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aApolipoproteins B
_xblood
650 0 4 _aCholesterol
_xblood
650 0 4 _aCholesterol, VLDL
_xblood
650 0 4 _aFatty Liver
_xcomplications
650 0 4 _aHepacivirus
_xmetabolism
650 0 4 _aHepatitis C, Chronic
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLipids
_xblood
650 0 4 _aLipoproteins, LDL
_xblood
700 1 _aSheridan, D A
700 1 _aBridge, S H
700 1 _aFelmlee, D J
700 1 _aNeely, R D G
773 0 _tSeminars in immunopathology
_gvol. 35
_gno. 1
_gp. 87-100
856 4 0 _uhttps://doi.org/10.1007/s00281-012-0356-2
_zAvailable from publisher's website
999 _c22225506
_d22225506